Alvaro is a physician graduated from the University of Chile, Santiago, Chile, after completing his medical education in 2019. He has been conducting research within systemic lupus erythematosus together with Dr. Parodis since 2017, and since December 2020, he has been a doctoral student at the Karolinska Institutet.

With the main goal of optimising the use of biological therapies in patients with SLE, Alvaro and colleagues have been studying how demographical, clinical, and immunological factors influence their efficacy.

"We are also exploring the impact of pharmacological and non-pharmacological factors on various patient-reported outcomes, and the performance of patient-reported measures as evaluation tools in clinical trials. I believe that our work highlights the importance of the patient perspective in clinical research and healthcare. One of my main interests is the effective communication of results in research. We strive to achieve it in our texts and data visualisation, both in scientific articles and when reaching broader audiences" says Dr. Alvaro Gomez Gonzalez.